Skip to content

Clinical trials

Terminated Neuromuscular Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuromuscular Diseases Status: Terminated Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20131
20141
20161
20173
20192
20202
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Flex Pharma, Inc.2
Fulcrum Therapeutics2
Albert Einstein Healthcare Network1
Baxter Healthcare Corporation1
Catabasis Pharmaceuticals1
Columbia University1
Kaiser Permanente1
Kyntra Bio1
National Institute of Neurological Disorders and Stroke (NINDS)1
National Institute of Nursing Research (NINR)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuromuscular Diseases15
Muscular Dystrophies6
Musculoskeletal Diseases6
Nervous System Diseases5
Muscular Diseases3
Muscular Dystrophy, Duchenne3
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Muscle Cramp2
Muscular Disorders, Atrophic2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.